The membrane-bound form of angiotensin converting enzyme 2 (ACE2) is essential for enabling infection with SARS-CoV-2, the virus that causes COVID-19, according to a study published in the journal Cell.
/PRNewswire/ Angiotensin Therapeutics Inc. ("Angiotensin" or the "Company"), a privately-held biopharmaceutical company focused on developing new therapies.
/PRNewswire/ Angiotensin Therapeutics Inc. ("Angiotensin" or the "Company"), a privately-held biopharmaceutical company focused on developing new therapies.
Kidney biopsies from a handful of patients signaled possible renal damage linked with long-term use of ACE inhibitors or ARBs, but with unclear clinical consequences.